KRT3 and breast cancer: On the right side, in the overall group (n = 150, 150 CBs), type OK1 was identified in 33.33% of BC, type OK3a in 2%, type OK3b in 2%, type SK2a in 46.67%, type CK1 in 6%, and type CK3 in 10% (Figure 2B).